United States Xarelto Market Report 2016

October 2016 | 123 pages | ID: U6FC01FE66BEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Xarelto

Revenue, means the sales value of Xarelto

This report studies sales (consumption) of Xarelto in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Xarelto in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Xarelto Market Report 2016

1 XARELTO OVERVIEW

1.1 Product Overview and Scope of Xarelto
1.2 Classification of Xarelto
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Xarelto
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Xarelto (2011-2021)
  1.4.1 United States Xarelto Sales and Growth Rate (2011-2021)
  1.4.2 United States Xarelto Revenue and Growth Rate (2011-2021)

2 UNITED STATES XARELTO COMPETITION BY MANUFACTURERS

2.1 United States Xarelto Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Xarelto Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Xarelto Average Price by Manufactures (2015 and 2016)
2.4 Xarelto Market Competitive Situation and Trends
  2.4.1 Xarelto Market Concentration Rate
  2.4.2 Xarelto Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES XARELTO SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Xarelto Sales and Market Share by Type (2011-2016)
3.2 United States Xarelto Revenue and Market Share by Type (2011-2016)
3.3 United States Xarelto Price by Type (2011-2016)
3.4 United States Xarelto Sales Growth Rate by Type (2011-2016)

4 UNITED STATES XARELTO SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Xarelto Sales and Market Share by Application (2011-2016)
4.2 United States Xarelto Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES XARELTO MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Xarelto Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
  5.2.2 Xarelto Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer Healthcare AG (Germany) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
  5.3.2 Xarelto Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc. (UK) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
  5.4.2 Xarelto Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Boehringer Ingelheim (Germany) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
  5.5.2 Xarelto Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Sanofi S.A. (France) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
  5.6.2 Xarelto Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abbott India Limited (India) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
  5.7.2 Xarelto Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Aspen Holdings (South Africa) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
  5.8.2 Xarelto Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bristol-Myers Squibb Company (US) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
  5.9.2 Xarelto Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Eisai Inc. (US) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  5.10.2 Xarelto Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)

6 XARELTO MANUFACTURING COST ANALYSIS

6.1 Xarelto Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Xarelto

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Xarelto Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Xarelto Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES XARELTO MARKET FORECAST (2016-2021)

10.1 United States Xarelto Sales, Revenue Forecast (2016-2021)
10.2 United States Xarelto Sales Forecast by Type (2016-2021)
10.3 United States Xarelto Sales Forecast by Application (2016-2021)
10.4 Xarelto Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Xarelto
Table Classification of Xarelto
Figure United States Sales Market Share of Xarelto by Type in 2015
Table Application of Xarelto
Figure United States Sales Market Share of Xarelto by Application in 2015
Figure United States Xarelto Sales and Growth Rate (2011-2021)
Figure United States Xarelto Revenue and Growth Rate (2011-2021)
Table United States Xarelto Sales of Key Manufacturers (2015 and 2016)
Table United States Xarelto Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Xarelto Sales Share by Manufacturers
Figure 2016 Xarelto Sales Share by Manufacturers
Table United States Xarelto Revenue by Manufacturers (2015 and 2016)
Table United States Xarelto Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Xarelto Revenue Share by Manufacturers
Table 2016 United States Xarelto Revenue Share by Manufacturers
Table United States Market Xarelto Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Xarelto Average Price of Key Manufacturers in 2015
Figure Xarelto Market Share of Top 3 Manufacturers
Figure Xarelto Market Share of Top 5 Manufacturers
Table United States Xarelto Sales by Type (2011-2016)
Table United States Xarelto Sales Share by Type (2011-2016)
Figure United States Xarelto Sales Market Share by Type in 2015
Table United States Xarelto Revenue and Market Share by Type (2011-2016)
Table United States Xarelto Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Xarelto by Type (2011-2016)
Table United States Xarelto Price by Type (2011-2016)
Figure United States Xarelto Sales Growth Rate by Type (2011-2016)
Table United States Xarelto Sales by Application (2011-2016)
Table United States Xarelto Sales Market Share by Application (2011-2016)
Figure United States Xarelto Sales Market Share by Application in 2015
Table United States Xarelto Sales Growth Rate by Application (2011-2016)
Figure United States Xarelto Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Xarelto Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Xarelto Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Xarelto Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Xarelto Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Xarelto Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Xarelto Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Xarelto Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Xarelto Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Xarelto Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Xarelto Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Xarelto Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Xarelto
Figure Manufacturing Process Analysis of Xarelto
Figure Xarelto Industrial Chain Analysis
Table Raw Materials Sources of Xarelto Major Manufacturers in 2015
Table Major Buyers of Xarelto
Table Distributors/Traders List
Figure United States Xarelto Production and Growth Rate Forecast (2016-2021)
Figure United States Xarelto Revenue and Growth Rate Forecast (2016-2021)
Table United States Xarelto Production Forecast by Type (2016-2021)
Table United States Xarelto Consumption Forecast by Application (2016-2021)